Jeremy P Hatch, MD | |
75 Baylor Dr, Suite 155, Bluffton, SC 29910-8965 | |
(843) 682-7480 | |
(843) 705-7034 |
Full Name | Jeremy P Hatch |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 75 Baylor Dr, Bluffton, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1801838248 | NPI | - | NPPES |
1014109 | Medicaid | VT | |
P00618356 | Other | VT | RAILROAD MEDICARE |
365526 | Medicaid | SC |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 042-0011130 (Vermont) | Secondary |
207X00000X | Orthopaedic Surgery | 2036552 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jeremy P Hatch, MD 272 Bamberg Dr, Bluffton, SC 29910-7400 Ph: (802) 370-2879 | Jeremy P Hatch, MD 75 Baylor Dr, Suite 155, Bluffton, SC 29910-8965 Ph: (843) 682-7480 |
News Archive
TomoTherapy Incorporated, maker of the TomoTherapy® treatment system for advanced, CT-guided radiation therapy, announced today that it has signed an equipment supply group purchasing agreement with GNYHA Services, Inc. Pursuant to this agreement, TomoTherapy technology will be made available at contracted rates to more than 220 member hospitals in New York, New Jersey, Pennsylvania and Puerto Rico.
Senate Majority Leader Harry Reid's efforts to merge the two Senate health care reform bills is being complicated by question of whether to include a public plan and how it might fit with vote counting, the president's agenda and the more liberal version sure to come out of the House.
A recent study, conducted at Dartmouth-Hitchcock Medical Center in Lebanon, NH, suggests that more vigilant prescribing guidelines could reduce the number of opioid pills a patient receives after surgery, whilst still meeting pain management needs.
Essential medications can be delivered as inhaled drugs to critically ill patients in the Intensive Care Unit (ICU) who require mechanical ventilation to breathe. Aerosol drug delivery is highly complex, however, and if not done properly the medication will not reach the lungs and therapy will be ineffective.
Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a U.S. and Canada, voluntary market withdrawal of CoZmonitor Blood Glucose Monitoring Systems. The FDA has been apprised of this action.
› Verified 7 days ago